The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Gorozhanin V.A.

Burdenko Neurosurgical Institute, Moscow, Russia

Pilipenko Iu.V.

FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

Belousova O.B.

NII neĭrokhirurgii im. akad. N.N. Burdenko RAMN, Moskva

Éliava Sh.Sh.

NII neĭrokhirurgii im. akad. N.N. Burdenko RAMN, Moskva

Microsurgical treatment of non-bleeding cerebral arteriovenous malformations

Authors:

Gorozhanin V.A., Pilipenko Iu.V., Belousova O.B., Éliava Sh.Sh.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2018;82(5): 119‑124

DOI: 10.17116/neiro201882051119

Read: 1525 times

Download PDF (RU)
Download PDF
Contact the author
Table of contents

MICROSURGICAL TREATMENT OF NON-BLEEDING CEREBRAL ARTERIOVENOUS MALFORMATIONS
MICROSURGICAL TREATMENT OF NON-BLEEDING CEREBRAL ARTERIOVENOUS MALFORMATIONS

To cite this article:

Gorozhanin VA, Pilipenko IuV, Belousova OB, Éliava ShSh. Microsurgical treatment of non-bleeding cerebral arteriovenous malformations. Burdenko's Journal of Neurosurgery. 2018;82(5):119‑124. (In Russ., In Engl.)
https://doi.org/10.17116/neiro201882051119

Подписка 2025 Журнал «Вопросы нейрохирургии» имени Н.Н. Бурденко (Burdenko's Journal of Neurosurgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Histopathological characteristics of vascular anomalies of the maxi­llofacial region in young children. Russian Journal of Operative Surgery and Clinical Anatomy. 2024;(4-2):16-23
Combined treatment of high-risk cere­bral arte­riovenous malformations acco­rding to Spetzler-Martin classification. Burdenko's Journal of Neurosurgery. 2025;(2):104-112
Abstract:

Treatment of non-bleeding cerebral arteriovenous malformations (AVMs) causes a lot of controversy among neurosurgeons around the world. The most discussed issue is choosing the method and indications for a certain treatment option. Despite the accumulated data, including the results of randomized studies, there is no consensus on this issue among experts. The purpose of this review is to analyze current concepts of the management and reasonability of microsurgical treatment of non-bleeding cerebral AVMs based on the latest published studies.

Keywords:

arteriovenous malformations
unruptured AVM
microsurgical treatment of AVM
ARUBA

Authors:

Gorozhanin V.A.

Burdenko Neurosurgical Institute, Moscow, Russia

Pilipenko Iu.V.

FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

Belousova O.B.

NII neĭrokhirurgii im. akad. N.N. Burdenko RAMN, Moskva

Éliava Sh.Sh.

NII neĭrokhirurgii im. akad. N.N. Burdenko RAMN, Moskva

Close metadata

References:

  1. Brow RDJr, Wiebers DO, Torner JC, O’Fallon WM. Frequency of intracranial hemorrhage as a presenting symptom and subtype analysis: a population-based study of intracranial vascular malformations in Olmsted Country, Minnesota. J Neurosurg. 1996;85(1):29-32. https://doi.org/10.3171/jns.1996.85.1.0029
  2. Stapf C, Mast H, Sciacca RR, Choi JH, Khaw AV, Connolly ES, Pile-Spellman J, Mohr JP. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66(9):1350-1355. https://doi.org/10.1212/01.wnl.0000210524.68507.87
  3. Kim H, Sidney S, McCulloch CE, Poon KY, Singh V, Johnston SC, Ko NU, Achrol AS, Lawton MT, Higashida RT, Young WL. Racial/Ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke. 2007;38(9):2430-2437. https://doi.org/10.1161/strokeaha.107.485573
  4. Yamada S, Takagi Y, Nozaki K, Kikuta K, Hashimoto N. Risk factors for subsequent hemorrhage in patients with cerebral arteriovenous malformations. J Neurosurg. 2007;107(5):965-972. https://doi.org/10.3171/jns-07/11/0965
  5. Gross BA, Du R. Natural history of cerebral arteriovenous malformations: a metaanalysis. J Neurosurg. 2013;118(2):437-443. https://doi.org/10.3171/2012.10.jns121280
  6. Derdeyn CP, Zipfel GJ, Albuquerque FC, Cooke DL, Feldmann E, Sheehan JP, Torner JC. Management of brain arteriovenous malformations: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2017;48(8):e200-e224. https://doi.org/10.1161/str.0000000000000134
  7. Van Beijnum J, Lovelock CE, Cordonnier C, Rothwell PM, Klijn CJ, Al-Shahi Salman R. Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies. Brain. 2009;132(Pt 2):537-543. https://doi.org/10.1093/brain/awn318
  8. Van Beijnum J, van der Worp HB, Buis DR, Al-Shahi Salman R, Kappelle LJ, Rinkel GJ, van der Sprenkel JW, Vandertop WP, Algra A, Klijn CJ. Treatment of brain arteriovenous malformations: a systematic review and metaanalysis. JAMA. 2011;306(18):2011-2019. https://doi.org/10.1001/jama.2011.1632
  9. Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, Al-Shahi Salman R, Vicaut E, Young WL, Houdart E, Cordonnier C, Stefani MA, Hartmann A, von Kummer R, Biondi A, Berkefeld J, Klijn CJ, Harkness K, Libman R, Barreau X, Moskowitz AJ. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. 2014;383(9917):614-621. https://doi.org/10.1016/s0140-6736(13)62302-8
  10. Cockroft KM, Jayaraman MV, Amin-Hanjani S, Derdeyn CP, McDougall CG, Wilson JA. A perfect storm: how a randomized trial of unruptured brain arteriovenous malformations’ (ARUBA’s) trial design challenges notions of external validity. Stroke. 2012;43(7):1979-1981. https://doi.org/10.1161/strokeaha.112.652032
  11. Russin J, Spetzler R. Commentary: the ARUBA trial. Neurosurgery. 2014; 75(1):E96-E97. https://doi.org/10.1227/neu.0000000000000357
  12. Knopman J, Stieg PE. Management of unruptured brain arteriovenous malformations. Lancet. 2014;383(9917):581-583. https://doi.org/10.1016/s0140-6736(14)60001-5
  13. Al-Shahi Salman R, White PM, Counsell CE, du Plessis J, van Beijnum J, Josephson CB, Wilkinson T, Wedderburn CJ, Chandy Z, St George EJ, Sellar RJ, Warlow CP. Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. JAMA. 2014;311(16):1661-1669. https://doi.org/10.1001/jama.2014.3200
  14. Potts MB, Lau D, Abla AA, Kim H, Young WL, Lawton MT. Current surgical results with low-grade brain arteriovenous malformations. J Neurosurg. 2015;122(4):912-920. https://doi.org/10.3171/2014.12.jns14938
  15. Katsaridis V, Papagiannaki C, Aimar E. Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology. 2008;50(7):589-597. https://doi.org/10.1007/s00234-008-0382-x
  16. Lunsford LD, Kondziolka D, Flickinger JC, Bissonette DJ, Jungreis CA, Maitz AH, Horton JA, Coffey RJ. Stereotactic radiosurgery for arteriovenous malformations of the brain. J Neurosurg. 1991;75(4):512-524. https://doi.org/10.3171/jns.1991.75.4.0512
  17. Mounayer C, Hammami N, Piotin M, Spelle L, Benndorf G, Kessler I, Moret J. Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol. 2007;28(3):518-523.
  18. Pierot L, Cognard C, Herbreteau D, Fransen H, van Rooij WJ, Boccardi E, Beltramello A, Sourour N, Kupcs K, Biondi A, Bonafe A, Reith W, Casasco A. Endovascular treatment of brain arteriovenous malformations using a liquid embolic agent: results of a prospective, multicentre study (BRAVO). Eur Radiol. 2013;23(10):2838-2845. https://doi.org/10.1007/s00330-013-2870-6
  19. Steiner L, Lindquist C, Adler JR, Torner JC, Alves W, Steiner M. Clinical outcome of radiosurgery for cerebral arteriovenous malformations. J Neurosurg. 1992;77(1):1-8. https://doi.org/10.3171/jns.1992.77.1.0001
  20. Baharvahdat H, Blanc R, Termechi R, Pistocch SI, Bartolin BI, Redjem H, Piotin M. Hemorrhagic complications after endovascular treatment of cerebral arteriovenous malformations. AJNR Am J Neuroradiol. 2014;35(5):978-983. https://doi.org/10.3174/ajnr.A3906
  21. Shen X, Liu J, Lv X, Li Y. Risk of rupture and risks of endovascular management of unruptured brain arteriovenous malformations. Interv Neuroradiol. 2014;20(4):495-501. https://doi.org/10.15274/nrj-2014-1004610.15274/inr-2014-10046
  22. Davidson AS, Morgan MK. How safe is arteriovenous malformation surgery? A prospective, observational study of surgery as first-line treatment for brain arteriovenous malformations. Neurosurgery. 2010;66(3):498-504; discussion 504-505. https://doi.org/10.1227/01.neu.0000365518.47684.98
  23. Morgan MK, Rochford AM, Tsahtsarlis A, Little N, Faulder KC. Surgical risks associated with the management of Grade I and II brain arteriovenous malformations. Neurosurgery. 2004;54(4):832-837; discussion 837-839.
  24. Zaidi HA, Russin JJ, Spetzler RF. Conservative management vs intervention for unruptured brain arteriovenous malformations. JAMA. 2014;312(10):1058. https://doi.org/10.1001/jama.2014.8751
  25. Starke RM, Sheehan JP, Ding D, Liu KC, Kondziolka D, Crowley RW, Lunsford LD, Kassell NF. Conservative management or intervention for unruptured brain arteriovenous malformations. World Neurosurg. 2014;82(5):e668-e669. https://doi.org/10.1016/j.wneu.2014.07.001
  26. Bambakidis NC, Cockroft KM, Hirsch JA, Connolly ES, Amin-Hanjani S, Meyers PM, Friedlander RM. The case against a randomized trial of unruptured brain arteriovenous malformations: misinterpretation of a flawed study. Stroke. 2014;45(9):2808-2810. https://doi.org/10.1161/strokeaha.114.006519
  27. Cenzato M, Boccardi E, Beghi E, Vajkoczy P, Szikora I, Motti E, Regli L, Raabe A, Eliava S, Gruber A, Meling TR, Niemela M, Pasqualin A, Golanov A, Karlsson B, Kemeny A, Liscak R, Lippitz B, Radatz M, La Camera A, Chapot R, Islak C, Spelle L, Debernardi A, Agostoni E, Revay M, Morgan MK. European consensus conference on unruptured brain AVMs treatment (Supported by EANS, ESMINT, EGKS, and SINCH). Acta Neurochir (Wien). 2017;159(6):1059-1064. https://doi.org/10.1007/s00701-017-3154-8
  28. Wong J, Slomovic A, Ibrahim G, Radovanovic I, Tymianski M. Microsurgery for ARUBA Trial (A Randomized Trial of Unruptured Brain Arteriovenous Malformation)-Eligible Unruptured Brain Arteriovenous Malformations. Stroke. 2017;48(1):136-144. https://doi.org/10.1161/strokeaha.116.014660
  29. Javadpour M, Al-Mahfoudh R, Mitchell PS, Kirollos R. Outcome of microsurgical excision of unruptured brain arteriovenous malformations in ARUBA-eligible patients. Br J Neurosurg. 2016;30(6):619-622. https://doi.org/10.1080/02688697.2016.1181153
  30. Schramm J, Schaller K, Esche J, Bostrom A. Microsurgery for cerebral arteriovenous malformations: subgroup outcomes in a consecutive series of 288 cases. J Neurosurg. 2017;126(4):1056-1063. https://doi.org/10.3171/2016.4.jns153017
  31. Nerva JD, Mantovani A, Barber J, Kim LJ, Rockhill JK, Hallam DK, Ghodke BV, Sekhar LN. Treatment outcomes of unruptured arteriovenous malformations with a subgroup analysis of ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-eligible patients. Neurosurgery. 2015;76(5):563-570; discussion 570; quiz 570. https://doi.org/10.1227/neu.0000000000000663
  32. Rutledge WC, Abla AA, Nelson J, Halbach VV, Kim H, Lawton MT. Treatment and outcomes of ARUBA-eligible patients with unruptured brain arteriovenous malformations at a single institution. Neurosurg Focus. 2014;37(3):E8. https://doi.org/10.3171/2014.7.focus14242
  33. Elhammady MS, Heros RC. Management of incidental cerebral AVMs in the post-ARUBA era. J Neurosurg. 2014;121(5):1011-1014. https://doi.org/10.3171/2014.3.jns14135
  34. Bervini D, Morgan MK, Ritson EA, Heller G. Surgery for unruptured arteriovenous malformations of the brain is better than conservative management for selected cases: a prospective cohort study. J Neurosurg. 2014;121(4):878-890. https://doi.org/10.3171/2014.7.jns132691
  35. Teo M, St.George E, Lawton M. Time for Barbados after ARUBA trial. 2015;29:1-2.
  36. Darsaut TE, Magro E, Gentric J-C, Batista AL, Chaalala C, Roberge D, Bojanowski MW, Weill A, Roy D, Raymond J. Treatment of brain AVMs (TOBAS): study protocol for a pragmatic randomized controlled trial. Trials. 2015;16:497. https://doi.org/10.1186/s13063-015-1019-0
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.